Trials / Unknown
UnknownNCT04293159
Effect of Probiotic on Constipation in Patients With Parkinson's Disease
Effect of Probiotic on Constipation and on Neuropsychological Performance in Patients With Parkinson's Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Salerno · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to collect data for the assessment of the Lactobacillus casei DG (Enterolactis ®duo) effect on constipation and on neuropsychological performance
Detailed description
The aim of the study is to collect data for the assessment of the Lactobacillus casei DG (Enterolactis® duo) effect on overall abdominal pain, bowel movements and other abdominal symptoms and on neuropsychological performance in patients with Parkinson's Disease. The investigators suppose that, due to the immunomodulatory action of probiotics, overall neuropsychological function will improve as well as due also to prebiotic abdominal symptoms will decrease following consumption of Lactobacillus casei DG (Enterolactis® duo).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactobacillus casei DG (Enterolactis duo®) | Lactobacillus casei DG (Enterolactis duo®) |
Timeline
- Start date
- 2019-05-14
- Primary completion
- 2022-12-01
- Completion
- 2023-06-01
- First posted
- 2020-03-03
- Last updated
- 2022-05-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04293159. Inclusion in this directory is not an endorsement.